Delivery Order SPE2DE21D7020-SPE2D625F3LQE
- Not listed
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- The Defense Health Agency's Medical Supply Chain has awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons, with a ceiling value of approximately $19.9K and an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment provisions was awarded on September 15, 2025, with no set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at Boston Scientific's...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $18,918.66 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on June 27, 2025. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of July 7, 2025. The place of performance is located in Marlborough, MA, where Boston Scientific...
- Boston Scientific Corp has been awarded a delivery order valued at $8,150.20 for agent drug-coated balloons under a Defense Health Agency Medical Supply Chain contract. The award, issued on September 16, 2025, with a completion date of September 19, 2025, utilizes fixed-price pricing with economic price adjustment terms. The contract carries no set-aside designation, indicating open competition in the federal marketplace. Performance will be executed at Boston Scientific's Marlborough,...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- Boston Scientific Corp has been awarded a delivery order by the Defense Health Agency's Medical Supply Chain for agent drug-coated balloons, with a contract ceiling value of $6,175. The award, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, is structured as a fixed-price contract with economic price adjustment provisions. The place of performance is Boston Scientific's headquarters in Marlborough, Massachusetts. This delivery order represents no set-aside...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F3LQEDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $41,639.42 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of September 22, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The award leverages Boston Scientific's established capabilities as a major supplier of advanced cardiovascular medical devices to federal healthcare systems. The place of performance is located in Marlborough, Massachusetts, where Boston Scientific maintains its headquarters and primary manufacturing operations. This delivery order is part of Boston Scientific's broader relationship with the Defense Health Agency, which has previously awarded the company numerous contracts for specialized medical technologies including stents, catheters, and other interventional cardiology devices. Drug-coated balloons represent a critical component of cardiovascular intervention procedures used across military healthcare facilities and the Veterans Affairs system. Boston Scientific's extensive portfolio of federal contracts and its designation as a sole-source supplier for certain specialized medical technologies underscore its strategic importance to the federal healthcare supply chain. The company's demonstrated expertise in device manufacturing, regulatory compliance, and rapid delivery capabilities position it as a preferred provider for time-sensitive medical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.6k | 9/15/25 |